Belpointe Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Sell |
|
|||||
|
2025
Q1 | $1.94M | Buy |
|
|||||
|
2024
Q4 | $605K | Sell |
|
|||||
|
2024
Q3 | $580K | Buy |
|
|||||
|
2024
Q2 | $517K | Buy |
|
|||||
|
2024
Q1 | $429K | Buy |
|
|||||
|
2023
Q4 | $297K | Buy |
|
|||||
|
2023
Q3 | $236K | Sell |
|
|||||
|
2023
Q2 | $323K | Sell |
|
|||||
|
2023
Q1 | $477K | Sell |
|
|||||
|
2022
Q4 | $1.4M | Sell |
|
|||||
|
2022
Q3 | $2.01M | Buy |
|
|||||
|
2022
Q2 | $1.5M | Sell |
|
|||||
|
2022
Q1 | $1.48M | Sell |
|
|||||
|
2021
Q4 | $1.29M | Buy |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $1.1M | Buy |
|
|||||
|
2021
Q1 | $976K | Buy |
|
|||||
|
2020
Q4 | $258K | Buy |
|
|||||
|
2020
Q3 | $201K | Sell |
|
|||||
|
2020
Q2 | $580K | Buy |
|
|||||
|
2020
Q1 | $405K | Sell |
|
|||||
|
2019
Q4 | $628K | Buy |
|